PharmacovigilanceOfficial
ANSM lifts pharmacist blister checks for Arrow lenalidomide but keeps handling precautions
🇫🇷 ANSM · Thu 19 Nov 2026
After Arrow introduced visual control of every blister, France's regulator says pharmacists no longer need to inspect lenalidomide packs, while glove and pregnancy-exposure rules still apply.
ANSM updated its notice on a lenalidomide quality defect on 19 November 2026. Arrow has put in place corrective measures that include visual inspection of each lenalidomide blister, so pharmacists are no longer required to check blisters systematically. They may dispense boxes to patients without opening them first.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Article written by VigiEye from the official source (ANSM). AI-assisted; check the source before acting.
More Pharmacovigilance
All →
FDA early alert: Heraeus Medevio recalls vascular guidewires over hydrophilic coating clumping risk
🇺🇸 FDA MedWatch · Fri 20 Nov 2026
EMA publishes PSUSA outcome for ibuprofen medicines, concluding with a variation
🇪🇺 EMA · Fri 20 Nov 2026
EMA publishes PSUSA outcome for nationally authorised split-virion inactivated influenza vaccines, recommending a variation
🇪🇺 EMA · Fri 20 Nov 2026
CMS proposes Medicare Advantage rule to ease market entry and widen beneficiary choice
🇺🇸 CMS · Fri 20 Nov 2026
CMS issues proposed rule on 2028 Medicare Advantage and Part D changes
🇺🇸 CMS · Fri 20 Nov 2026
FDA warns Florida clinical investigator over consent failings in INSTI HIV self-test study
🇺🇸 FDA CBER · Fri 20 Nov 2026